z-logo
open-access-imgOpen Access
PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA
Author(s) -
M. Yu. Frolov,
О. В. Шаталова
Publication year - 2017
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909.2017.10.2.053-061
Subject(s) - pomalidomide , lenalidomide , bortezomib , multiple myeloma , medicine , refractory (planetary science) , thalidomide , oncology , physics , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here